← Leaderboards
Andrei Iagaru
Stanford University
$3,258,317
Attributed
$5,289,847
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2017–21$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,289,847 · 2
By mechanism
U01$4,063,060 · 1
R01$1,226,787 · 1
Top collaborators
- Walter Gwang-Up Park5 shared
Most similar at Stanford University
Same institution · by research overlap
- Chris John Diederich$7,720,462
- Lei Xing$18,542,508
- Ruijiang Li$10,760,802
- Shan X. Wang$16,205,138
- Walter Gwang-Up Park$7,872,399
Others in their field
Other Emerging Leaders on “Recurrence”
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Kevin Navin Sheth · Brigham And Women'S Hospital$10,362,027
- Dale Sandler · Social And Scientific Systems, Inc.$9,632,923
- Zhiyong Yang · Fzata, Inc.$7,816,062
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,152,405
- Phillip W Graham · Research Triangle Institute$7,075,871
Research focus
RecurrenceScheduleMagnetic Resonance ImagingPositron-Emission TomographyTumorTissuesEvaluationLesionMalignant NeoplasmsPerformanceSuccessStainsTechnologyDiagnosisBaseEarly DiagnosisFollow-UpImageBindingClinical ResearchMolecular ImagingOverexpressionDetectionBiological Markers
Grant awards (8)
Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma$667,441
U01 · FY2021 · CA · contact PI
Evaluation of Patients with Low-Risk and Intermediate-Risk Prostate Cancer Scheduled for High-Dose Rate Brachytherapy Using 68Ga-RM2 PET, 68Ga-PSMA-11 PET and Multi Parametric MRI$1
R01 · FY2021 · CA · contact PI
Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma$938,249
U01 · FY2020 · CA · contact PI
Evaluation of Patients with Low-Risk and Intermediate-Risk Prostate Cancer Scheduled for High-Dose Rate Brachytherapy Using 68Ga-RM2 PET, 68Ga-PSMA-11 PET and Multi Parametric MRI$612,442
R01 · FY2020 · CA · contact PI
Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma$917,296
U01 · FY2019 · CA · contact PI
Evaluation of Patients with Low-Risk and Intermediate-Risk Prostate Cancer Scheduled for High-Dose Rate Brachytherapy Using 68Ga-RM2 PET, 68Ga-PSMA-11 PET and Multi Parametric MRI$614,344
R01 · FY2019 · CA · contact PI
Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma$936,814
U01 · FY2018 · CA · contact PI
Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma$603,260
U01 · FY2017 · CA · contact PI